Summary:
Allergy and Asthma Associates Santa Clara Valley Research Center is conducting a research study to demonstrate that Symbicort is more effective than formoterol for prevention of COPD exacerbations. You are being asked to take part in this study because you have the diagnosis of COPD.
Qualified Participants Must:
Have a diagnosis of COPD for 1 at least a year
Be 40 years of age or older
Have smoked or are currently smoking
Have at least 1 Dr's visit for COPD in the past year
Have no history of asthma
Qualified Participants May Receive:
Compensation for time and travel and potential study medication.